Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Lori Ashby"'
Autor:
Abraham J. Qavi, Caroline E. Franks, Gary Grajales-Reyes, Jeanne Anderson, Lori Ashby, Kimberly Zohner, Ann M. Gronowski, Christopher W. Farnsworth
Publikováno v:
Clinical biochemistry.
Quantity not sufficient (QNS) specimens with minimal blood volume for testing are common in clinical laboratories. However, there is no universal definition of minimum volume for a QNS specimen and little data is available addressing the impact of QN
Autor:
David Luechtefeld, Ann M. Gronowski, Max Amurao, Areti Marko, Christopher G. Suciu, Lori Ashby
Publikováno v:
Clinical chemistry. 67(10)
Background Biological specimens from patients who have received radiopharmaceuticals are often collected for diagnostic testing and sent to clinical laboratories. Residual radiation has long been assumed to be minimal. However, literature is sparse a
Publikováno v:
Clinical Biochemistry. 48:815-817
Objective Previous work has documented the ability of the Clearblue Advanced Test with Weeks Estimator, a new over-the-counter (OTC) urine hCG device, to accurately estimate weeks since ovulation in early pregnancy. In this study, the performance of
Autor:
Lori Ashby, Patrick H. Conway, Jamie Hermansen, Tamara Syrek Jensen, Joseph S. Chin, Joseph D Hutter
Publikováno v:
New England Journal of Medicine. 372:2083-2085
Thanks to recent evidence that screening with low-dose computed tomography reduces lung-cancer mortality, at-risk U.S. patients 55 to 77 years of age are now eligible for a screening benefit under Medicare, while further data are collected and assess
Autor:
Lori Ashby, Alison Woodworth, Ann M. Gronowski, Mark A. Cervinski, Mitchell G. Scott, Ulf-Håkan Stenman
Publikováno v:
Clinical Chemistry. 55:1389-1394
Background: During pregnancy, human chorionic gonadotropin (hCG) immunoreactivity in urine consists of intact hCG as well as a number of hCG variants including the core fragment of hCGβ (hCGβcf). We identified 3 urine specimens with apparent false-
Publikováno v:
Clinical Chemistry. 47:2064-2066
Decentralized testing is becoming more common as technology lends itself to the development of accurate point-of-care testing devices. The i-STAT® System (Abbott) is used at our institution in two same-day outpatient surgery centers to measure elect
Publikováno v:
Clinical Chemistry. 55:1885-1886
Recently, we reported that increased concentrations of human chorionic gonadotropin β core fragment (hCGβcf)1 can cause false-negative results on the OSOM® hCG Combo Test (Genzyme Diagnostics) and ICON® 25 hCG (Beckman Coulter) qualitative urine